A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 10, 2017

Study Completion Date

July 10, 2017

Conditions
Rhinitis Allergic
Interventions
DRUG

triamcinolone XRG5029

"Pharmaceutical form: spray solution~Route of administration: nasal"

DRUG

fluticasone

"Pharmaceutical form: spray solution~Route of administration: nasal"

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY